PCS3117
Julie Frank, Young Bok Lee, Deog Joong Kim, Ely Benaim Rexahn Pharmaceuticals, Inc., Rockville, MD
View Publication
PCS3117
Drew W. Rasco, Christine Peterson, Reza Mazhari, Ely Benaim and Jaime R. Merchan, South Texas Accelerated Research Therapeutics, San Antonio, TX, 2Rexahn Pharmaceuticals Inc., Rockville, MD, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
View Publication
PCS3117
Drew W. Rasco, Christine Peterson, Reza Mazhari, Ely Benaim and Jaime R. Merchan, South Texas Accelerated Research Therapeutics, San Antonio, TX, Rexahn Pharmaceuticals Inc., Rockville, MD, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
View Publication
PCS3117
Vincent Chung, Jaime R. Merchan, Allyson J. Ocean, Drew W. Rasco, Hani M. Babiker, Ira Oliff, Ravi Kumar Paluri, Eloy Roman, Julie Poore, Ely Benaim; City of Hope, Duarte, CA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL; 3Weill Cornell Medical College, New York, NY; South Texas Accelerated Research Therapeutics, San Antonio, TX; University of Arizona Cancer Center, Tucson, AZ; 6Orchard Healthcare Research, Inc., Skokie, IL; University of Alabama at Birmingham, Birmingham, AL; Lakes Research, Miami Lakes, FL; Rexahn Pharmaceuticals Inc., Rockville, MD
View Publication
PCS3117
Meghan Salgia , Sumanta K. Pal , Vincent M. Chung , Scott T. Tagawa , Joel Picus , Hani M. Babiker , Sumati Gupta , Julie Poore , Christine Peterson , and Ely Benaim ; City of Hope, Duarte, CA; Weill Cornell Medical College, New York, NY; Washington University in St. Louis School of Medicine, St. Louis, MO; 4 University of Arizona Cancer Center, Tucson, AZ; 5 University of Utah Huntsman Cancer Institute, Salt Lake City, UT; 6 Rexahn Pharmaceuticals Inc., Rockville, MD
View Publication
PCS3117
In vitro models: - A549 and SW1573 non-small cell lung cancer (NSCLC) cell lines - Cells were cultured in DMEM plus 10% fetal bovine serum - A panel of various cell lines with different UCK activity In vivo models: - a panel of cells from various xenografts - 3 xenograft models with different sensitivity to RX-3117 and UCK activity Godefridus J. Peters, Joris R Julsing, Kees Smid, Daniel de Klerk, Dzjemma Sarkisjan, Mi Young Yang, Young Bok Lee, Deog Joong Kim,
View Publication
PCS3117
Drew W. Rasco, Christine Peterson, Ely Benaim and Jaime R. Merchan. South Texas Accelerated Research Therapeutics, San Antonio, TX, Rexahn Pharmaceuticals Inc., Rockville, MD, 3Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
View Publication
PCS3117
Hani M. Babiker, Peter N. Schlegel, Lee G. Hicks, Andrea Bullock, NafisaJ. Burhani, Ely Benaim, Callie Heaton, Christine Peterson6, Allyson J. Ocean7 1University of Arizona Cancer Center, Tucson, AZ, USA; Cancer Care Northwest, Spokane, WA, USA; Baptist Health Lexington, Lexington, KY, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA; Joliet Oncology-Hematology Associates Ltd., Joliet, IL, USA; Rexahn Pharmaceuticals, Inc., Rockville, MD, USA; New York Presbyterian-Weill Cornell Medical Center, New York, NY, USA.
View Publication
PCS3117
BABIKER H, SCHLEGEL P, BENAIM E, HEATON CM, PETERSON C, OCEAN A University of Arizona Cancer Center, Tucson, AZ, USA; 2 Cancer Care Northwest, Spokane, WA, USA; 3 Rexahn Pharmaceuticals, Inc., Rockville, MD, USA ; 4 New York Presbyterian-Weill Cornell Medical Center, New York, NY, USA
View Publication
PCS3117
Nicholas Salgia, SumantaK. Pal, Vincent Chung, Scott T. Tagawa, Joel Picus3, Hani M. Babiker4, SumatiGupta5, Raymond Couric Wadlow, Julie Poore, Christine Peterson, Ely Benaim
View Publication